Literature DB >> 8987084

New cationic lipid formulations for gene transfer.

F Liu1, J Yang, L Huang, D Liu.   

Abstract

PURPOSE: To develop appropriate dosage forms of DNA for gene delivery.
METHODS: 3 beta [N-(N', N' dimethylaminoethane) carbamoyl] cholesterol (DC-Chol) was mixed either with Tween 80 alone, or with additional lipid components including castor oil and phosphatidylcholine (PC) or dioleoylphosphatidylethanolamine (DOPE) to make different lipid formulations. The particle size and the physical stability of the formulations upon mixing with plasmid DNA containing the luciferase cDNA were examined using laser light scattering measurement. The transfection activity of the DNA/lipid complexes was tested in presence or absence of serum using a cell culture system.
RESULTS: We demonstrated that many favorable properties as a gene carrier could be achieved by formulating DNA into new dosage forms using Tween 80 as the major emulsifier. Compared to the cationic liposomes, these new formulations transfected different cell lines with an equivalent or higher efficiency. Not only are they resistant to serum, but also form stable DNA complexes which could be stored for longer periods of time without losing transfection activity.
CONCLUSIONS: Cationic lipids formulated into different lipid formulations using Tween 80 as a surfactant appeared to have more favorable physical and biological activities than traditional cationic liposomes as a carrier for gene delivery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8987084     DOI: 10.1023/a:1016041326636

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

Review 1.  Human gene therapy.

Authors:  W F Anderson
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

Review 2.  Cationic liposome-mediated gene transfer.

Authors:  X Gao; L Huang
Journal:  Gene Ther       Date:  1995-12       Impact factor: 5.250

3.  A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA.

Authors:  J G Lewis; K Y Lin; A Kothavale; W M Flanagan; M D Matteucci; R B DePrince; R A Mook; R W Hendren; R W Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  Liposomes as agents of DNA transfer.

Authors:  J G Smith; R L Walzem; J B German
Journal:  Biochim Biophys Acta       Date:  1993-12-21

5.  Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.

Authors:  T A Smith; M G Mehaffey; D B Kayda; J M Saunders; S Yei; B C Trapnell; A McClelland; M Kaleko
Journal:  Nat Genet       Date:  1993-12       Impact factor: 38.330

Review 6.  The basic science of gene therapy.

Authors:  R C Mulligan
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

Review 7.  Gene therapy, concepts, current trials and future directions.

Authors:  P Tolstoshev
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

Review 8.  Concepts and strategies for human gene therapy.

Authors:  K Roemer; T Friedmann
Journal:  Eur J Biochem       Date:  1992-09-01

9.  A novel cationic liposome reagent for efficient transfection of mammalian cells.

Authors:  X Gao; L Huang
Journal:  Biochem Biophys Res Commun       Date:  1991-08-30       Impact factor: 3.575

10.  Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.

Authors:  G J Nabel; E G Nabel; Z Y Yang; B A Fox; G E Plautz; X Gao; L Huang; S Shu; D Gordon; A E Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more
  14 in total

Review 1.  Dendritic cell delivery of plasmid DNA. Applications for controlled genetic immunization.

Authors:  R J Mumper; H C Ledebur
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

2.  Mechanisms of lipoplex formation: dependence of the biological properties of transfection complexes on formulation procedures.

Authors:  V A Rakhmanova; E V Pozharski; R C MacDonald
Journal:  J Membr Biol       Date:  2004-07-01       Impact factor: 1.843

Review 3.  Gene therapy.

Authors:  M A Kay; D Liu; P M Hoogerbrugge
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  HIF1A overexpression using cell-penetrating DNA-binding protein induces angiogenesis in vitro and in vivo.

Authors:  Mijeong Jeon; Yooseok Shin; Jaeeun Jung; Ui-Won Jung; Jae-Hoon Lee; Jae-Seung Moon; Ilkoo Kim; Jin-Su Shin; Sang-Kyou Lee; Je Seon Song
Journal:  Mol Cell Biochem       Date:  2017-06-28       Impact factor: 3.396

5.  A cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery system.

Authors:  S W Yi; T Y Yune; T W Kim; H Chung; Y W Choi; I C Kwon; E B Lee; S Y Jeong
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

6.  3Beta [N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol)-mediated gene delivery to primary rat neurons: characterization and mechanism.

Authors:  P S Ajmani; J A Hughes
Journal:  Neurochem Res       Date:  1999-05       Impact factor: 3.996

7.  Polysorbate cationic synthetic vesicle for gene delivery.

Authors:  Yongzhuo Huang; Yuefeng Rao; Jinliang Chen; Victor C Yang; Wenquan Liang
Journal:  J Biomed Mater Res A       Date:  2011-01-04       Impact factor: 4.396

8.  Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen.

Authors:  Vincent W Bramwell; Jim E Eyles; Satyanarayana Somavarapu; H Oya Alpar
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

9.  Site-specific delivery of oligonucleotides to hepatocytes after systemic administration.

Authors:  Lin Zhu; Zhaoyang Ye; Kun Cheng; Duane D Miller; Ram I Mahato
Journal:  Bioconjug Chem       Date:  2007-09-13       Impact factor: 4.774

10.  Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia.

Authors:  Yan Jin; Shujun Liu; Bo Yu; Sharon Golan; Chee-Guan Koh; Jintao Yang; Lenguyen Huynh; Xiaojuan Yang; Jiuxia Pang; Natarajan Muthusamy; Kenneth K Chan; John C Byrd; Yeshayahu Talmon; L James Lee; Robert J Lee; Guido Marcucci
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.